The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/63894
ICON plc Leopardstown, Dublin, Ireland www.iconplc.com 353-1-2912000 Main Service Areas: Bioanalytical, Clinical, Preclinical Key locations: China, Germany, India, Ireland, Japan, United States Contact: Paul Colombo, VP sales, U.S. business development info@iconplc.com SERVICES & CAPABILITIES: Phase I-IV clinical trial design, management and review, clinical pharmacology, bioanalytical and central labs, biomarkers, pharmacodynamic/pharmacokinetic analysis, data management, medical and safety, biostatistics, interactive technologies, patient recruitment, medical imaging, contract resourcing THERAPEUTIC AREAS: Oncology, cardiovascular, CNS, endocrine and metabolic disorders, biosimilars, gastrointestinal, transplant and immunology, infectious disease and vaccines, dermatology, haematology, musculoskeletal, respiratory, genitourinary KEY INDUSTRY PARTNERS: Pfizer; Ely Lilly; Shire; Bristol-Myers Squibb TNERS: xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxx "ICON's leadership ranking in this industry survey is testament to the expertise and dedication of ICON employees around the world who deliver quality programs to clients. We will continue to be a proactive and innovative provider of solutions that help clients maximize the effectiveness of their R&D; activities and bring new drugs to market more cost effectively and efficiently." — Dr. Steve Cutler, group president, clinical research services INC Research Raleigh, NC www.incresearch.com (919) 876-9300 Main Service Areas: Clinical Key locations: Australia, China, India, Mexico, United Kingdom, United States Contact: John Musante, senior VP, business development info@incresearch.com SERVICES & CAPABILITIES: Phase I - IV clinical services include biometrics, clinical monitoring, drug safety, FSP /strategic alliances, patient recruitment/retention, project management, regulatory affairs, strategic consulting THERAPEUTIC AREAS: Cardiovascular, CNS, dermatology, endocrinology, gastroenterology, immunology, infectious diseases, inflammation, oncology, ophthalmology, respiratory with special expertise in pediatrics, and women's health populations "INC Research prides itself on building strong relationships with its customers and consistently and efficiently delivering quality clinical development services on their behalf. This focus is the essence of the Trusted Process®, our proprietary, metrics-driven clinical outsourcing methodology specifically designed to reduce variability and increase productivity while remaining flexible to meet our customers' complex and changing needs." — Jim Ogle, CEO LabCorp Clinical Trials Cranford, NJ www.labcorp.com/clinicaltrials (877) 788-8861 Main Service Areas: Clinical SERVICES & CAPABILITIES: Biomarkers, biorepository, coagulation, companion diagnostics, cytogenetics, endocrinology, flow cytometry, infectious disease, in vitro diagnostic device, pharmco- genetics, Phase 1, safety THERAPEUTIC AREAS: Laboratory services for all therapeutic areas KEY INDUSTRY PARTNERS: Monogram Biosciences, a LabCorp Company; Tandem Labs, a LabCorp Company; The Biomarker Factory, a venture with Duke University Medical Center; M.U.R.D.O.C.K. Study, The Measurement to Understand Reclassification of Disease of Cabarrus and Kannapolis, an initiative between Duke University and LabCorp Biorepository; David H. Murdock Research Institute (DHMRI) "LabCorp approaches each new project with an innovative, scientific mindset. This pioneering attitude has led to many advances across the life sciences. The goal with the development of each new tactic is to use our technical expertise and wealth of resources within LabCorp to deliver greater value and more flexible solutions in helping our clients bring new medicines to market faster." — David M. Johnston, Ph.D., senior vice president, global head, clinical trials The CRO Leadership Awards 2012 24 Key locations: Belgium, Canada, China, Germany, Singapore, United States Contact: Shailesh Maingi clintrialssales@labcorp.com